{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:26:44Z","timestamp":1675045604382},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00115-018-0597-y","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T09:16:52Z","timestamp":1536830212000},"page":"1095-1105","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuroimmunologie und Rheumatologie: Schnittmengen und Differenzialdiagnosen"],"prefix":"10.1007","volume":"89","author":[{"given":"C.","family":"Trebst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"K\u00fcmpfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"key":"597_CR1","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s00415-006-0137-8","volume":"253","author":"G Akman-Demir","year":"2006","unstructured":"Akman-Demir G, Gul A, Gurol E et al (2006) Inflammatory\/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? J\u00a0Neurol 253:928\u2013934","journal-title":"J Neurol"},{"key":"597_CR2","first-page":"84","volume":"119","author":"E Auriel","year":"2014","unstructured":"Auriel E, Regev K, Korczyn AD (2014) Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. Handb Clin Neurol 119:84","journal-title":"Handb Clin Neurol"},{"key":"597_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jns.2009.08.060","volume":"287","author":"S Bolat","year":"2009","unstructured":"Bolat S, Berding G, Dengler R et al (2009) Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. J\u00a0Neurol Sci 287:257\u2013159","journal-title":"J Neurol Sci"},{"key":"597_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jaut.2011.08.002","volume":"37","author":"AT Borchers","year":"2011","unstructured":"Borchers AT, Leibushor N, Cheema GS et al (2011) Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases. J\u00a0Autoimmun 37:273\u2013288","journal-title":"J Autoimmun"},{"key":"597_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S1474-4422(06)70572-5","volume":"5","author":"A Charil","year":"2006","unstructured":"Charil A, Yousry TA, Rovaris M et\u00a0al (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of \u201eno better explanation\u201c. Lancet Neurol 5:841\u2013852","journal-title":"Lancet Neurol"},{"key":"597_CR6","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s00415-012-6790-1","volume":"260","author":"R Dobson","year":"2013","unstructured":"Dobson R, Giovannoni G (2013) Autoimmune disease in people with multiple sclerosis and their relatives: a\u00a0systematic review and meta-analysis. J\u00a0Neurol 260:1272\u20131285","journal-title":"J Neurol"},{"key":"597_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jocn.2017.06.031","volume":"44","author":"V Fominykh","year":"2017","unstructured":"Fominykh V, Shevtsova T, Arzumanian N et\u00a0al (2017) Coexistence of multiple sclerosis and ankylosing spondylitis: Report of four cases from Russia and review of the literature. J\u00a0Clin Neurosci 44:230\u2013233","journal-title":"J Clin Neurosci"},{"key":"597_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrneurol.2018.14","volume":"14","author":"R Geraldes","year":"2018","unstructured":"Geraldes R, Ciccarelli O, Barkhof F et\u00a0al (2018) The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol 14:199\u2013213","journal-title":"Nat Rev Neurol"},{"key":"597_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/2156-7514.80373","volume":"1","author":"DT Ginat","year":"2011","unstructured":"Ginat DT, Dhillon G, Almast J (2011) Magnetic resonance imaging of neurosarcoidosis. J\u00a0Clin Imaging Sci 1:15","journal-title":"J Clin Imaging Sci"},{"key":"597_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12311-013-0528-1","volume":"13","author":"I Gonz\u00e1lez-Su\u00e1rez","year":"2014","unstructured":"Gonz\u00e1lez-Su\u00e1rez I, Aguilar-Amat MJ, Trigueros M et al (2014) Leukoencephalopathy due to oral methotrexate. Cerebellum 13:178\u2013183","journal-title":"Cerebellum"},{"issue":"1","key":"597_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12883-018-1018-3","volume":"18","author":"T Hottenrott","year":"2018","unstructured":"Hottenrott T, Dersch R, Berger B et\u00a0al (2018) The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis. Bmc Neurol 18(1):14. \n                    https:\/\/doi.org\/10.1186\/s12883-018-1018-3","journal-title":"Bmc Neurol"},{"key":"597_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00415-016-8336-4","volume":"264","author":"RT Ibitoye","year":"2017","unstructured":"Ibitoye RT, Wilkins A, Scolding NJ (2017) Neurosarcoidosis: a\u00a0clinical approach to diagnosis and management. J\u00a0Neurol 264:1023\u20131028","journal-title":"J Neurol"},{"key":"597_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3109\/08916934.2014.883501","volume":"47","author":"A Iyer","year":"2014","unstructured":"Iyer A, Elsone L, Appleton R, Jacob A (2014) A review of the current literature and a\u00a0guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica. Autoimmunity 47:154\u2013161","journal-title":"Autoimmunity"},{"issue":"1","key":"597_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B et\u00a0al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J\u00a0Neuroinflammation 9(1):14. \n                    https:\/\/doi.org\/10.1186\/1742-2094-9-14","journal-title":"J Neuroinflammation"},{"issue":"1","key":"597_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a\u00a0multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J\u00a0Neuroinflammation 13(1):280. \n                    https:\/\/doi.org\/10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"issue":"12","key":"597_CR16","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S (2017) Woodhall MRet al Clinical presentation and prognosis in MOG-antibody disease: a\u00a0UK study. Brain 140(12):3128\u20133138","journal-title":"Brain"},{"key":"597_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00393-016-0158-3","volume":"75","author":"JB K\u00fcmmerle-Deschner","year":"2016","unstructured":"K\u00fcmmerle-Deschner JB (2016) Autoinflammatory syndromes : Practical approach to diagnostics and therapy. Z\u00a0Rheumatol 75:542\u2013555","journal-title":"Z Rheumatol"},{"issue":"8","key":"597_CR18","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/art.22795","volume":"56","author":"T K\u00fcmpfel","year":"2007","unstructured":"K\u00fcmpfel T, Hoffmann LA, R\u00fcbsamen H et al (2007) Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation. Arthritis Rheum 56(8):2774\u20132783. \n                    https:\/\/doi.org\/10.1002\/art.22795","journal-title":"Arthritis Rheum"},{"key":"597_CR19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1177\/1352458512437813","volume":"18","author":"T K\u00fcmpfel","year":"2012","unstructured":"K\u00fcmpfel T, Gerdes LA, Wacker T et al (2012) Familial Mediterranean fever-associated mutation pyrin E148Q as a\u00a0potential risk factor for multiple sclerosis. Mult Scler 18:1229\u20131238","journal-title":"Mult Scler"},{"key":"597_CR20","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00415-008-0882-y","volume":"255","author":"A Kurne","year":"2008","unstructured":"Kurne A, Isikay IC, Karlioguz K (2008) Clinically isolated syndrome: a\u00a0challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation. J\u00a0Neurol 255:1625\u20131635","journal-title":"J Neurol"},{"issue":"7","key":"597_CR21","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/1352458510369146","volume":"16","author":"A Langer-Gould","year":"2010","unstructured":"Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM (2010) Autoimmune diseases prior to the diagnosis of multiple sclerosis: a\u00a0population-based case-control study. Mult Scler 16(7):855\u2013861. \n                    https:\/\/doi.org\/10.1177\/1352458510369146","journal-title":"Mult Scler"},{"key":"597_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00281-015-0500-x","volume":"37","author":"MA Lee-Kirsch","year":"2015","unstructured":"Lee-Kirsch MA, Wolf C, Kretschmer S et al (2015) Type I interferonopathies \u2013 an expanding disease spectrum of immunodysregulation. Semin Immunopathol 37:349\u2013357","journal-title":"Semin Immunopathol"},{"key":"597_CR23","first-page":"93","volume":"31","author":"S Luger","year":"2013","unstructured":"Luger S, Harter PN, Mittelbronn M et\u00a0al (2013) Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis. Clin Exp Rheumatol 31:93\u201395","journal-title":"Clin Exp Rheumatol"},{"key":"597_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/art.40356","volume":"70","author":"S Mader","year":"2018","unstructured":"Mader S, Jeganathan V, Arinuma Y et\u00a0al (2018) Understanding the antibody repertoire in neuropsychiatric systemic lupus Erythematosus and Neuromyelitis Optica spectrum disorder: do they share common targets? Arthritis Rheumatol 70:277\u2013286","journal-title":"Arthritis Rheumatol"},{"key":"597_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ana.25146","volume":"83","author":"P Maggi","year":"2018","unstructured":"Maggi P, Absinta M, Grammatico M et\u00a0al (2018) Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol 83:283\u2013294","journal-title":"Ann Neurol"},{"key":"597_CR26","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170523144402","author":"D Mauro","year":"2017","unstructured":"Mauro D, Barbagallo G, D\u2019Angelo S et\u00a0al (2017) Role of positron emission tomography for central nervous system involvement in systemic autoimmune diseases: status and perspectives. Curr Med Chem 24. \n                    https:\/\/doi.org\/10.2174\/0929867324666170523144402","journal-title":"Curr Med Chem"},{"key":"597_CR27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/jnnp.58.5.548","volume":"58","author":"BN McLean","year":"1995","unstructured":"McLean BN, Miller D, Thompson E (1995) Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Beh\u00e7et\u2019s disease involving the nervous system. J Neurol Neurosurg Psychiatr 58:548\u2013554","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"597_CR28","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1177\/1352458515575338","volume":"21","author":"L Negrotto","year":"2015","unstructured":"Negrotto L, Tur C, Tintor\u00e9 M et al (2015) Should we systematically test patients with clinically isolated syndrome for auto-antibodies? Mult Scler 21:1802\u20131810","journal-title":"Mult Scler"},{"key":"597_CR29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/1352458508088936","volume":"14","author":"NM Nielsen","year":"2008","unstructured":"Nielsen NM, Frisch M, Rostgaard K et al (2008) Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a\u00a0nationwide cohort study in Denmark. Mult Scler 14:823\u2013829","journal-title":"Mult. Scler."},{"key":"597_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/0961203317691373","volume":"26","author":"M Postal","year":"2017","unstructured":"Postal M, Lapa AT, Reis F et\u00a0al (2017) Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches. Lupus 26:517\u2013521","journal-title":"Lupus"},{"key":"597_CR31","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1212\/NXI.0000000000000109","volume":"2","author":"E Schuh","year":"2015","unstructured":"Schuh E, Lohse P, Ertl-Wagner B et al (2015) Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations. Neurol Neuroimmunol Neuroinflamm 2:e109","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"57","key":"597_CR32","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1212\/WNL.57.8.1359","volume":"23","author":"J Seze de","year":"2001","unstructured":"Seze J de, Devos D, Castelnovo G et\u00a0al (2001) The prevalence of Sj\u00f6gren syndrome in patients with primary progressive multiple sclerosis. Neurology 23(57):1359\u20131363","journal-title":"Neurology"},{"key":"597_CR33","first-page":"e6","volume":"8","author":"AJ Solomon","year":"2013","unstructured":"Solomon AJ, Hills W, Chen Z et\u00a0al (2013) Autoantibodies and Sjogren\u2019s Syndrome in multiple sclerosis, a\u00a0reappraisal. PLoS ONE 8:e6","journal-title":"PLoS ONE"},{"key":"597_CR34","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1212\/WNL.0000000000003152","volume":"87","author":"AJ Solomon","year":"2016","unstructured":"Solomon AJ, Bourdette DN, Cross AH et\u00a0al (2016) The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology 87:1393\u20131399","journal-title":"Neurology"},{"key":"597_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","volume":"9","author":"CS Tan","year":"2010","unstructured":"Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9:425\u2013437","journal-title":"Lancet Neurol"},{"key":"597_CR36","first-page":"290","volume":"77","author":"A Theodoridou","year":"2006","unstructured":"Theodoridou A, Settas L (2006) Demyelination in rheumatic diseases. J\u00a0Neurol Neurosurg Psychiatr 77:290\u2013295","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"597_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"A Thompson","year":"2018","unstructured":"Thompson A, Banwell BL, Barkhof F et\u00a0al (2018) Diagnosis of multiple sclerosis: recommended 2017 revisions of the \u201cMcDonald\u201d criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"597_CR38","first-page":"1027","volume":"33","author":"E Toussirot","year":"2006","unstructured":"Toussirot E, Pertuiset E, Martin A et\u00a0al (2006) Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significance. J\u00a0Rheumatol 33:1027\u20131028","journal-title":"J Rheumatol"},{"key":"597_CR39","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrneurol.2011.176","volume":"7","author":"C Trebst","year":"2011","unstructured":"Trebst C, Raab P, Voss EV et\u00a0al (2011) Longitudinal extensive transverse myelitis \u2013 it\u2019s not all neuromyelitis optica. Nat Rev Neurol 7:688\u2013698","journal-title":"Nat Rev Neurol"},{"key":"597_CR40","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1212\/01.wnl.0000260226.21010.2b","volume":"68","author":"B Wildemann","year":"2007","unstructured":"Wildemann B, Rudofsky G Jr., Kress B et al (2007) The tumor necrosis factor-associated periodic syndrome, the brain, and tumor necrosis factor-alpha antagonists. Neurology 68:1742\u20131744","journal-title":"Neurology"},{"key":"597_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et\u00a0al (2015) International Panel for NMO Diagnosis. Neurology 85:177\u2013189","journal-title":"Neurology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-018-0597-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T23:21:55Z","timestamp":1568330515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-018-0597-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1007\/s00115-018-0597-y","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,13]]},"assertion":[{"value":"13 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Trebst hat Honorare f\u00fcr Vortr\u00e4ge auf Fortbildungsveranstaltungen von Biogen Idec\/GmbH, Genzyme GmbH und Novartis Pharmaceuticals erhalten. Dies hatte keinen Einfluss auf die vorliegende Arbeit. T.\u00a0K\u00fcmpfel erhielt finanzielle Unterst\u00fctzung f\u00fcr Reisen und Vortragst\u00e4tigkeiten von Bayer Healthcare, Teva Pharma, Merck, Novartis Pharma, Sanofi-Aventis\/Genzyme, CLB Behring, Roche Pharma und Biogen sowie Unterst\u00fctzung f\u00fcr wissenschaftliche Projekte von Bayer-Schering AG, Novartis und Chugai Pharma. Dies hatte keinen Einfluss auf die vorliegende Arbeit.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autorinnen durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}